Alaunos Therapeutics (TCRT) Deferred Taxes (2009 - 2019)
Alaunos Therapeutics' (TCRT) quarterly Deferred Taxes came in at -$17000.0 in Q4 2019, down 30.77% YoY from -$24555.6 in Q4 2018, and down 200.0% on a QoQ basis from $17000.0 in Q1 2019.
Alaunos Therapeutics (TCRT) Deferred Taxes (2009 - 2019) Analysis & Trends
Alaunos Therapeutics (TCRT) has 11 years of Deferred Taxes data on file, last reported at -$17000.0 in Q4 2019.
- Quarterly Deferred Taxes fell 30.77% year-over-year to -$17000.0 in Q4 2019, while the trailing twelve-month figure through Sep 2019 was $4000.0 (up 102.68% YoY) and the FY2018 annual result came in at -$125000.0, up 10.07% from the prior year.
- Deferred Taxes slipped to -$17000.0 in Q4 2019, from $17000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $108000.0 in Q1 2015 to a low of -$148000.0 in Q2 2016.
- A 5-year average of -$46277.8 and a median of -$37000.0 in 2017 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2015 — Deferred Taxes soared 329.79% — and 2016, when it tumbled 184.26%.
- Tracing TCRT's Deferred Taxes over 5 years: stood at -$120000.0 in 2015, then soared by 51.67% to -$58000.0 in 2016, then surged by 36.21% to -$37000.0 in 2017, then surged by 64.86% to -$13000.0 in 2018, then tumbled by 30.77% to -$17000.0 in 2019.
- The last three Deferred Taxes figures came in at -$17000.0 (Q4 2019), $17000.0 (Q1 2019), and -$13000.0 (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -17,000.00 |
| Mar 31, 2019 | 17,000.00 |
| Dec 31, 2018 | -13,000.00 |
| Sep 30, 2018 | -38,000.00 |
| Jun 30, 2018 | -37,000.00 |
| Mar 31, 2018 | -37,000.00 |
| Dec 31, 2017 | -37,000.00 |
| Sep 30, 2017 | -37,000.00 |
| Jun 30, 2017 | -34,000.00 |
| Mar 31, 2017 | -31,000.00 |
| Dec 31, 2016 | -58,000.00 |
| Sep 30, 2016 | -83,000.00 |
| Jun 30, 2016 | -148,000.00 |
| Mar 31, 2016 | -91,000.00 |
| Dec 31, 2015 | -120,000.00 |
| Sep 30, 2015 | -88,000.00 |
| Jun 30, 2015 | -89,000.00 |
| Mar 31, 2015 | 108,000.00 |
| Dec 31, 2014 | -59,000.00 |
| Sep 30, 2014 | -56,000.00 |